TickerFacts.

Volitionrx Ltd (VNRX): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the years ended 2016-12-31, 2017-12-31 (for example after a spin-off or a discontinued operation), while the year before each was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

-$20.75M
Year ended 2025-12-31
-$18.57M
Trailing 12 months to 2026-06-30
2011-12-31: -$2.49M2012-12-31: -$3.95M2013-12-31: -$4.43M2014-12-31: -$5.81M2015-12-31: -$9.77M2016-12-31: -$12.12M2017-12-31: -$14.17M2018-12-31: -$17.26M2019-12-31: -$15.37M2020-12-31: -$20.53M2021-12-31: -$27.39M2022-12-31: -$30.84M2023-12-31: -$34.84M2024-12-31: -$25.91M2025-12-31: -$20.75M-$20.75M
2011-12-31 EBITDA (USD) 2025-12-31
Period endedEBITDAChange YoYSource filing
2025-12-31-$20.75Mn/m2026-03-31, From 2025-01-01
2024-12-31-$25.91Mn/m2026-03-31, From 2024-01-01
2023-12-31-$34.84Mn/m2025-03-31, From 2023-01-01
2022-12-31-$30.84Mn/m2024-03-25, From 2022-01-01
2021-12-31-$27.39Mn/m2023-03-15, From 2021-01-01
2020-12-31-$20.53Mn/m2022-03-30, From 2020-01-01
2019-12-31-$15.37Mn/m2021-03-22, From 2019-01-01
2018-12-31-$17.26Mn/m2020-02-20, From 2018-01-01
2017-12-31-$14.17Mn/c2019-03-13, From 2017-01-01
2016-12-31-$12.12Mn/c2018-03-01, From 2016-01-01
2015-12-31-$9.77Mn/m2017-03-10, From 2015-01-01
2014-12-31-$5.81Mn/m2016-03-11, From 2014-01-01
2013-12-31-$4.43Mn/m2015-03-18, From 2013-01-01
2012-12-31-$3.95Mn/m2014-03-28, From 2012-01-01
2011-12-31-$2.49Mn/a2013-04-01, From 2011-01-01

EBITDA at similar companies

Companies with the same SEC industry code (In Vitro & In Vivo Diagnostic Substances), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEBITDAChange YoY
Volitionrx Ltd (VNRX)2025-12-31-$20.75Mn/m
Celldex Therapeutics, Inc. (CLDX)2025-12-31-$283.99Mn/m
Insight Molecular Diagnostics Inc. (IMDX)2025-12-31-$48.93Mn/m
Biomerica Inc (BMRA)2026-05-31-$5.24Mn/m
Aspira Women's Health Inc. (AWHL)2025-12-31-$7.80Mn/m
Immucell Corp (ICCC)2025-12-31$4.43M+306.8%
Alpha Teknova, Inc. (TKNO)2025-12-31-$10.63Mn/m
Intellia Therapeutics, Inc. (NTLA)2025-12-31-$431.22Mn/m
Cardio Diagnostics Holdings, Inc. (CDIO)2025-12-31-$6.42Mn/m

Compare VNRX, CLDX, IMDX, BMRA side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗